---
title: "Sensei Biotherapeutics (SNSE.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SNSE.US/norm.md"
symbol: "SNSE.US"
name: "Sensei Biotherapeutics"
parent: "https://longbridge.com/zh-CN/quote/SNSE.US.md"
datetime: "2026-05-21T18:01:31.327Z"
locales:
  - [en](https://longbridge.com/en/quote/SNSE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNSE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNSE.US/norm.md)
---

# Sensei Biotherapeutics (SNSE.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -131.45 | -3.74 | -3.62 | -3.91 | -5.45 |
| ROE | 1147.39% | -90.71% | -72.64% | -66.59% | -78.03% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M |
| 营业利润 | -170.63M | -4.96M | -4.85M | -5.21M | -7.27M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 205.38M | 22.90M | 27.59M | 31.78M | 38.27M |
| 权益乘数 | -1.50 | 1.23 | 1.20 | 1.16 | 1.20 |
| 每股净资产 | -102.43 | 14.74 | 18.24 | 21.66 | 25.38 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 202.79M | 21.18M | 25.04M | 28.63M | 34.33M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 982000.00 | 1.38M | 1.79M | 2.19M | 2.57M |
| 净债务 | -201.75M | -19.68M | -23.02M | -26.07M | -31.12M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -10.73M | -3.86M | -3.59M | -5.91M | -7.09M |
| 投资现金流 | -31.44M | 2.08M | 1.74M | 8.76M | 7.19M |
| 融资现金流 | 185.83M | -111000.00 | -152000.00 | -168000.00 | -214000.00 |
| 自由现金流 | -97.38M | -2.11M | -1.89M | -3.73M | -4.86M |
| 现金流充裕率 | -15783.82% | -3419.47% | -2359.21% | -1790.61% | -3362.09% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -6000.00 | 0.0000 | 0.0000 | -16000.00 | - |